ArticleMolecular oncology2021

Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomes.

Mikkel G Terp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.